
Sign up to save your podcasts
Or


Join our expert faculty for a discussion on new and emerging treatment strategies for patients with advanced GIST.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/936137?src=mkm_podcast_addon_936137
Join Drs Bhatt and Steg as they discuss the use of antiplatelet therapy to reduce cardiovascular risk in diabetes.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/935836?src=mkm_podcast_addon_935836
Two experts discuss the latest in antipsychotic therapy for patients with schizophrenia.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/935076?src=mkm_podcast_addon_935076
Drs Harper, Berson, and Graber discuss hitting the pathophysiologic targets of acne with treatment.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934863?src=mkm_podcast_addon_934863
Clinical implications of rapid diagnostic testing for suspected cases of meningitis and encephalitis.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934672?src=mkm_podcast_addon_934672
Hear expert best practices for managing patients with IBD in the time of COVID-19.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934572?src=mkm_podcast_addon_934572
Join our expert faculty to learn about assessing and managing pain in the school setting.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934153?src=mkm_podcast_addon_934153
In episode 2, Dr Luca Di Lullo reviews the use of NOACs in patients with new or worsening renal function.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934007?src=mkm_podcast_addon_934007
Join Prof Onyema Ogbuagu as he provides his expert perspective on vulnerable populations for COVID-19 in the United States..
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/933929?src=mkm_podcast_addon_933929
More than 60 compounds are in development for the treatment of NASH. Only one is nearing FDA approval.
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/934004?src=mkm_podcast_addon_934004
From the publisher's feed

136 Listeners

698 Listeners

498 Listeners

163 Listeners

103 Listeners

892 Listeners

13 Listeners

16 Listeners

291 Listeners

264 Listeners

3,353 Listeners

1,157 Listeners

196 Listeners

92 Listeners

520 Listeners

372 Listeners

171 Listeners

60 Listeners

8 Listeners

430 Listeners